Effective induction of antiglioma cytotoxic T cells by coadministration of heat-induction antigen by means of bio-nanoparticles dendritic cells
通过生物纳米粒子树突状细胞共同施用热诱导抗原有效诱导抗神经胶质瘤细胞毒性T细胞
基本信息
- 批准号:16390409
- 负责人:
- 金额:$ 9.28万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
As it is well known that heat-induction particles enhance the stimulatory activity of dendritic cells (DCs), we hypothesized that DCs in the presence of the heat-induction antigens would provide particularly effective antitumor activity against glioma cells by stimulating cytotoxic T cell. As a fundamental study, a rat glioma cell line T-98 was heated with bio-nano particles, magnetite, under the alternative magnetic field to continue the adequate concentration level of heat-induction antigens around the tumor cells, then cocultured with syngeneic bone marrow-derived DCs and naive splenic T cells. The T-98 cells were almost completely killed cocluture with DCs and T cells, and strong tumor-specific cytotoxic T lymphocyte (CTL) activity was induced. As a pre-clinical study, human DCs accumulated from peripheral blood CD14 positive monocyte was activated with IL-2 and GM-CSF and analyzed the expression of cytokine level in culture. Remarkable elevation of expression level of interleukin-12 and IFN-gamma could be observed in culture which may activate T lymphocytes. These result suggest that heat-induction antigen would stimulate DCs and induce antitumor immunity against glioma by coculturing with T lymphocytes which may act as displaying lytic activity against glioma.
众所周知,热诱导颗粒可增强树突状细胞 (DC) 的刺激活性,因此我们假设,在热诱导抗原存在下,DC 将通过刺激细胞毒性 T 细胞,对神经胶质瘤细胞提供特别有效的抗肿瘤活性。作为一项基础研究,大鼠神经胶质瘤细胞系 T-98 在交变磁场下用生物纳米颗粒、磁铁矿加热,以持续使肿瘤细胞周围的热诱导抗原达到足够的浓度水平,然后与同源骨髓来源的 DC 和初始脾 T 细胞共培养。 T-98细胞与DC和T细胞共混几乎被完全杀死,并诱导出强烈的肿瘤特异性细胞毒性T淋巴细胞(CTL)活性。作为一项临床前研究,用IL-2和GM-CSF激活从外周血CD14阳性单核细胞积累的人DC,并分析培养物中细胞因子水平的表达。在培养物中可以观察到白介素12和IFN-γ的表达水平显着升高,这可能激活T淋巴细胞。这些结果表明,热诱导抗原可以通过与T淋巴细胞共培养来刺激DC并诱导针对神经胶质瘤的抗肿瘤免疫,而T淋巴细胞可能表现出针对神经胶质瘤的裂解活性。
项目成果
期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Aurora-B dysfunction of multinucleated giant cells in glioma detected by site-specific phosphorylated antibodies
- DOI:10.3171/jns.2004.101.6.1012
- 发表时间:2004-12-01
- 期刊:
- 影响因子:4.1
- 作者:Fujita, M;Mizuno, M;Yoshida, J
- 通讯作者:Yoshida, J
Multicentric Atypical teratoid/Rhabdoid tumors occurring in the eye and fourth ventricle of an infant.
多中心非典型畸胎瘤样/横纹肌样肿瘤发生在婴儿的眼睛和第四脑室。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Fujita M;et al.
- 通讯作者:et al.
バイオナノテクノロジーを用いた温熱療法(先端医療シリーズ29・脳神経外科の最新医療)
利用生物纳米技术的热疗(高级医疗系列29/神经外科最新医疗)
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:若林俊彦;他
- 通讯作者:他
Interferon-beta gene therapy for cancer : basic research to clinical application.
癌症干扰素-β基因治疗:基础研究到临床应用。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Yoshida J;et al.
- 通讯作者:et al.
Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes.
- DOI:10.1089/10430340460732472
- 发表时间:2004-07
- 期刊:
- 影响因子:4.2
- 作者:J. Yoshida;M. Mizuno;M. Fujii;Y. Kajita;Norimoto Nakahara;M. Hatano;R. Saito;Misato Nobayashi;T. Wakabayashi
- 通讯作者:J. Yoshida;M. Mizuno;M. Fujii;Y. Kajita;Norimoto Nakahara;M. Hatano;R. Saito;Misato Nobayashi;T. Wakabayashi
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WAKABAYASHI Toshihiko其他文献
WAKABAYASHI Toshihiko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WAKABAYASHI Toshihiko', 18)}}的其他基金
Development of molecular imaging tracers for anticancer drug resistant proteins
抗癌耐药蛋白分子影像示踪剂的开发
- 批准号:
21390409 - 财政年份:2009
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Clinical evaluation of efficacy and safety of dendritic cell-based vaccine therapy using with HLA-A2 restricted IL-13 alpha receptor peptide in patients with malignant glioma managed by international organization for standardization
使用HLA-A2限制性IL-13α受体肽的树突状细胞疫苗疗法对国际标准化组织管理的恶性胶质瘤患者的疗效和安全性的临床评价
- 批准号:
18390395 - 财政年份:2006
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Induction of anti-tumor immunity by intracellular hyperthermia using magnetite
利用磁铁矿进行细胞内高温诱导抗肿瘤免疫
- 批准号:
14370430 - 财政年份:2002
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Antitumor activity by intracellular hyperthermia using magnetite
使用磁铁矿进行细胞内热疗的抗肿瘤活性
- 批准号:
11671365 - 财政年份:1999
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Specific Imaging and Intracellular Hyperthermia for Brain Tumor using Magnetite Particle conjugated with monoclonal antibody
使用与单克隆抗体结合的磁铁矿颗粒对脑肿瘤进行特异性成像和细胞内热疗
- 批准号:
08671574 - 财政年份:1996
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tenascin in cerebrospinal fluid is a useful biomarker for the diagosis of brain tumor
脑脊液中的腱蛋白是诊断脑肿瘤的有用生物标志物
- 批准号:
06671383 - 财政年份:1994
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Fundamental study of neuronal cell differentiation system by transfection with glial fibrillary acidic protein gene.
胶质纤维酸性蛋白基因转染神经细胞分化系统的基础研究。
- 批准号:
04670859 - 财政年份:1992
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Evaluating gamma-delta T cell therapy for osteosarcoma
评估骨肉瘤的 γ-δ T 细胞疗法
- 批准号:
MR/X033066/1 - 财政年份:2024
- 资助金额:
$ 9.28万 - 项目类别:
Fellowship
Design and evolution of deimmunized protein superglues to enhance modular cell therapy
去免疫蛋白强力胶的设计和进化以增强模块化细胞疗法
- 批准号:
MR/Y011910/1 - 财政年份:2024
- 资助金额:
$ 9.28万 - 项目类别:
Research Grant
Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
- 批准号:
10752046 - 财政年份:2024
- 资助金额:
$ 9.28万 - 项目类别:
Improving Chimeric Antigen Receptor (CAR) T-Cell Therapy Using Engineering Biology and Mechanobiological Approach
利用工程生物学和力学生物学方法改进嵌合抗原受体 (CAR) T 细胞疗法
- 批准号:
10074571 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:
Grant for R&D
Market Feasibility for a Engineering Biology Approach to Cell Therapy for Brain Cancer and Regenerative Medicine
脑癌和再生医学细胞治疗的工程生物学方法的市场可行性
- 批准号:
10074920 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:
Grant for R&D
A novel diagnostic tool leveraging AI for protein design and microfluidics for better cell therapy management
一种利用人工智能进行蛋白质设计和微流体技术以实现更好的细胞治疗管理的新型诊断工具
- 批准号:
10082156 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:
Collaborative R&D
Establishment of cell therapy using tissue stem cells derived from perifascial areolar tissue (PAT)
使用来自筋膜周围乳晕组织(PAT)的组织干细胞建立细胞疗法
- 批准号:
23K09089 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Engineering T cells to overcome inhibitory receptor signals that limit the efficacy of adoptive cell therapy against ovarian cancer
改造 T 细胞以克服抑制性受体信号,这些信号限制了过继性细胞疗法对卵巢癌的疗效
- 批准号:
10526155 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:
BioSynth Trust: Developing understanding and confidence in flow cytometry benchmarking synthetic datasets to improve clinical and cell therapy diagnos
BioSynth Trust:发展对流式细胞仪基准合成数据集的理解和信心,以改善临床和细胞治疗诊断
- 批准号:
2796588 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:
Studentship
Establishment of CAR-NK cell therapy using T/NK progenitor cells
利用T/NK祖细胞建立CAR-NK细胞疗法
- 批准号:
23K15308 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists